{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T12:05:05Z","timestamp":1793793905167,"version":"4.6.1"},"reference-count":137,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.bbalip.2014.12.001","type":"journal-article","created":{"date-parts":[[2014,12,12]],"date-time":"2014-12-12T23:00:38Z","timestamp":1418425238000},"page":"867-881","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Mendelian disorders of PI metabolizing enzymes"],"prefix":"10.1016","volume":"1851","author":[{"given":"Leopoldo","family":"Staiano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Giovanna","family":"De Leo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Persico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Antonietta","family":"De Matteis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbalip.2014.12.001_bb0005","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nature13302","article-title":"A draft map of the human proteome","volume":"509","author":"Kim","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bbalip.2014.12.001_bb0010","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nature13319","article-title":"Mass-spectrometry-based draft of the human proteome","volume":"509","author":"Wilhelm","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bbalip.2014.12.001_bb0015","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature10098","article-title":"Global quantification of mammalian gene expression control","volume":"473","author":"Schwanhausser","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bbalip.2014.12.001_bb0020","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.molmed.2012.04.004","article-title":"Myotubularin phosphoinositide phosphatases: cellular functions and disease pathophysiology","volume":"18","author":"Hnia","year":"2012","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0025","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ng0696-175","article-title":"A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast","volume":"13","author":"Laporte","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/75542","article-title":"Charcot\u2013Marie\u2013Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2","volume":"25","author":"Bolino","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0035","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/j.1600-0854.2008.00754.x","article-title":"Endosomal phosphoinositides and human diseases","volume":"9","author":"Nicot","year":"2008","journal-title":"Traffic"},{"key":"10.1016\/j.bbalip.2014.12.001_bb0040","first-page":"209","article-title":"Myotubularin phosphoinositide phosphatases in human diseases","volume":"362","author":"Amoasii","year":"2012","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0045","doi-asserted-by":"crossref","first-page":"e1002595","DOI":"10.1371\/journal.pgen.1002595","article-title":"Defective membrane remodeling in neuromuscular diseases: insights from animal models","volume":"8","author":"Cowling","year":"2012","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0050","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1128\/MCB.01075-12","article-title":"Defective autophagy and mTORC1 signaling in myotubularin null mice","volume":"33","author":"Fetalvero","year":"2013","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0055","doi-asserted-by":"crossref","first-page":"15060","DOI":"10.1073\/pnas.212498399","article-title":"The lipid phosphatase myotubularin is essential for skeletal muscle maintenance but not for myogenesis in mice","volume":"99","author":"Buj-Bello","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0060","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1096\/fj.12-220947","article-title":"Lack of myotubularin (MTM1) leads to muscle hypotrophy through unbalanced regulation of the autophagy and ubiquitin-proteasome pathways","volume":"27","author":"Al-Qusairi","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0065","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1093\/hmg\/ddl250","article-title":"A novel PtdIns3P and PtdIns(3,5)P2 phosphatase with an inactivating variant in centronuclear myopathy","volume":"15","author":"Tosch","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0070","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1083\/jcb.200407010","article-title":"Disruption of Mtmr2 produces CMT4B1-like neuropathy with myelin outfolding and impaired spermatogenesis","volume":"167","author":"Bolino","year":"2004","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0075","doi-asserted-by":"crossref","first-page":"8858","DOI":"10.1523\/JNEUROSCI.1423-09.2009","article-title":"Dlg1, Sec8, and Mtmr2 regulate membrane homeostasis in Schwann cell myelination","volume":"29","author":"Bolis","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pgen.1002319","article-title":"Genetic interaction between MTMR2 and Fig4 phospholipid phosphatases involved in Charcot\u2013Marie\u2013Tooth neuropathies","volume":"7","author":"Vaccari","year":"2011","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0085","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/hmg\/ddg030","article-title":"Mutation of the SBF2 gene, encoding a novel member of the myotubularin family, in Charcot\u2013Marie\u2013Tooth neuropathy type 4B2\/11p15","volume":"12","author":"Senderek","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0090","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1111\/j.1471-4159.2007.05103.x","article-title":"Multiple disease-linked myotubularin mutations cause NFL assembly defects in cultured cells and disrupt myotubularin dimerization","volume":"104","author":"Goryunov","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0095","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1086\/375034","article-title":"Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of Charcot\u2013Marie\u2013Tooth disease associated with early-onset glaucoma","volume":"72","author":"Azzedine","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0100","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/hmg\/dds562","article-title":"The CMT4B disease-causing phosphatases Mtmr2 and Mtmr13 localize to the Schwann cell cytoplasm and endomembrane compartments, where they depend upon each other to achieve wild-type levels of protein expression","volume":"22","author":"Ng","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0105","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/hmg\/ddi473","article-title":"Multi-level regulation of myotubularin-related protein-2 phosphatase activity by myotubularin-related protein-13\/set-binding factor-2","volume":"15","author":"Berger","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0110","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1212\/WNL.0b013e31829a3421","article-title":"SET binding factor 1 (SBF1) mutation causes Charcot\u2013Marie\u2013Tooth disease type 4B3","volume":"81","author":"Nakhro","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.bbalip.2014.12.001_bb0115","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1073\/pnas.0431052100","article-title":"Regulation of myotubularin-related (MTMR)2 phosphatidylinositol phosphatase by MTMR5, a catalytically inactive phosphatase","volume":"100","author":"Kim","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0120","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature05876","article-title":"Mutation of Fig4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J","volume":"448","author":"Chow","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.bbalip.2014.12.001_bb0125","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/jb\/mvt064","article-title":"Phosphatidylinositol-3,5-bisphosphate: metabolism and physiological functions","volume":"154","author":"Takasuga","year":"2013","journal-title":"J. Biochem."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0130","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1091\/mbc.E08-04-0405","article-title":"Assembly of a Fab1 phosphoinositide kinase signaling complex requires the Fig4 phosphoinositide phosphatase","volume":"19","author":"Botelho","year":"2008","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bbalip.2014.12.001_bb0135","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0960-9822(07)00513-1","article-title":"The stress-activated phosphatidylinositol 3-phosphate 5-kinase Fab1p is essential for vacuole function in S. cerevisiae","volume":"8","author":"Cooke","year":"1998","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0140","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ajhg.2008.12.010","article-title":"Deleterious variants of Fig4, a phosphoinositide phosphatase, in patients with ALS","volume":"84","author":"Chow","year":"2009","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0145","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1086\/520771","article-title":"Lethal contractural syndrome type 3 (LCCS3) is caused by a mutation in PIP5K1C, which encodes PIPKI gamma of the phophatidylinsitol pathway","volume":"81","author":"Narkis","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0150","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/OGX.0b013e31822bf5bb","article-title":"Arthrogryposis: a review and approach to prenatal diagnosis","volume":"66","author":"Rink","year":"2011","journal-title":"Obstet. Gynecol. Surv."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0155","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature02896","article-title":"Impaired PtdIns(4,5)P2 synthesis in nerve terminals produces defects in synaptic vesicle trafficking","volume":"431","author":"Di Paolo","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bbalip.2014.12.001_bb0160","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/ng1325","article-title":"Mutations in VPS33B, encoding a regulator of SNARE-dependent membrane fusion, cause arthrogryposis\u2013renal dysfunction\u2013cholestasis (ARC) syndrome","volume":"36","author":"Gissen","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0165","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/humu.21650","article-title":"A missense mutation in PIK3R5 gene in a family with ataxia and oculomotor apraxia","volume":"33","author":"Al Tassan","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0170","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/humu.22373","article-title":"Genetics, B.A. Oostra, P. Barone, J. Wang, V. Bonifati, Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset Parkinsonism","volume":"34","author":"Quadri","year":"2013","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0175","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/humu.22372","article-title":"The Sac1 domain of SYNJ1 identified mutated in a family with early-onset progressive Parkinsonism with generalized seizures","volume":"34","author":"Krebs","year":"2013","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0180","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/archpedi.1980.02130190017005","article-title":"Cleidocranial dysostosis, severe micrognathism, bilateral absence of thumbs and first metatarsal bone, and distal aphalangia: a new genetic syndrome","volume":"134","author":"Yunis","year":"1980","journal-title":"Am. J. Dis. Child."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0185","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.ajhg.2013.03.020","article-title":"Yunis\u2013Varon syndrome is caused by mutations in Fig4, encoding a phosphoinositide phosphatase","volume":"92","author":"Campeau","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0190","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/jmg.27.2.114","article-title":"Yunis\u2013Varon syndrome with severe osteodysplasty","volume":"27","author":"Garrett","year":"1990","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0195","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/ajmg.a.32135","article-title":"Yunis\u2013Varon syndrome: further delineation of the phenotype","volume":"146A","author":"Basel-Vanagaite","year":"2008","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bbalip.2014.12.001_bb0200","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/1096-8628(20001113)95:2<157::AID-AJMG12>3.0.CO;2-E","article-title":"Yunis\u2013Varon syndrome: evidence for a lysosomal storage disease","volume":"95","author":"Walch","year":"2000","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0205","first-page":"155","article-title":"A unique chondrodysplasia secondary to a defect in chondroosseous transformation","volume":"13","author":"Zonana","year":"1977","journal-title":"Birth Defects Orig. Artic. Ser."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0210","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ajmg.1320190117","article-title":"Opsismodysplasia: a new type of chondrodysplasia with predominant involvement of the bones of the hand and the vertebrae","volume":"19","author":"Maroteaux","year":"1984","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0215","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ajhg.2012.11.011","article-title":"Whole-genome analysis reveals that mutations in inositol polyphosphate phosphatase-like 1 cause opsismodysplasia","volume":"92","author":"Below","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0220","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/ajmg.a.33909","article-title":"Nosology and classification of genetic skeletal disorders: 2010 revision","volume":"155A","author":"Warman","year":"2011","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bbalip.2014.12.001_bb0225","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ajhg.2012.11.015","article-title":"Exome sequencing identifies INPPL1 mutations as a cause of opsismodysplasia","volume":"92","author":"Huber","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0230","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1182\/blood.V93.8.2707","article-title":"A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells","volume":"93","author":"Wisniewski","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bbalip.2014.12.001_bb0235","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/jhg.2013.25","article-title":"Exome sequencing identifies a novel INPPL1 mutation in opsismodysplasia","volume":"58","author":"Iida","year":"2013","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0240","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/35051094","article-title":"The lipid phosphatase SHIP2 controls insulin sensitivity","volume":"409","author":"Clement","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bbalip.2014.12.001_bb0245","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nm1178","article-title":"Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity","volume":"11","author":"Sleeman","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0250","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1002\/jcb.23146","article-title":"SHIP2 multiple functions: a balance between a negative control of PtdIns(3,4,5)P(3) level, a positive control of PtdIns(3,4)P(2) production, and intrinsic docking properties","volume":"112","author":"Erneux","year":"2011","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0255","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/bies.201100195","article-title":"Reversible Ser\/Thr SHIP phosphorylation: a new paradigm in phosphoinositide signalling?: targeting of SHIP1\/2 phosphatases may be controlled by phosphorylation on Ser and Thr residues","volume":"34","author":"Edimo","year":"2012","journal-title":"Bioessays"},{"key":"10.1016\/j.bbalip.2014.12.001_bb0260","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/ki.1981.200","article-title":"The Fanconi syndrome and mechanisms of tubular transport dysfunction","volume":"20","author":"Roth","year":"1981","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0265","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/21548331.1993.11442879","article-title":"The cellular basis of Fanconi syndrome","volume":"28","author":"Baum","year":"1993","journal-title":"Hosp. Pract. (Off. Ed.)"},{"key":"10.1016\/j.bbalip.2014.12.001_bb0270","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s004670050495","article-title":"The Fanconi syndrome of cystinosis: insights into the pathophysiology","volume":"12","author":"Baum","year":"1998","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0275","first-page":"164","article-title":"Organic-aciduria, decreased renal ammonia production, hydrophthalmos, and mental retardation; a clinical entity","volume":"83","author":"Lowe","year":"1952","journal-title":"AMA Am. J. Dis. Child."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0280","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/358239a0","article-title":"The Lowe's oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphatase","volume":"358","author":"Attree","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.bbalip.2014.12.001_bb0285","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1038\/emboj.2009.155","article-title":"A PH domain within OCRL bridges clathrin-mediated membrane trafficking to phosphoinositide metabolism","volume":"28","author":"Mao","year":"2009","journal-title":"EMBO J."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0290","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.tibs.2012.01.002","article-title":"Inositol 5-phosphatases: insights from the Lowe syndrome protein OCRL","volume":"37","author":"Pirruccello","year":"2012","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0295","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/bioinformatics\/btl022","article-title":"A novel domain suggests a ciliary function for ASPM, a brain size determining gene","volume":"22","author":"Ponting","year":"2006","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bbalip.2014.12.001_bb0300","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1093\/hmg\/ddg250","article-title":"Lowe syndrome protein OCRL1 interacts with Rac GTPase in the trans-Golgi network","volume":"12","author":"Faucherre","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0305","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1073\/pnas.92.11.4853","article-title":"The protein deficient in Lowe syndrome is a phosphatidylinositol-4,5-bisphosphate 5-phosphatase","volume":"92","author":"Zhang","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0310","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1074\/jbc.273.3.1574","article-title":"Cell lines from kidney proximal tubules of a patient with Lowe syndrome lack OCRL inositol polyphosphate 5-phosphatase and accumulate phosphatidylinositol 4,5-bisphosphate","volume":"273","author":"Zhang","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0315","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1093\/hmg\/ddr608","article-title":"Impaired neural development in a zebrafish model for Lowe syndrome","volume":"21","author":"Ramirez","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0320","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1172-1-16","article-title":"Lowe syndrome","volume":"1","author":"Loi","year":"2006","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0325","series-title":"GeneReviews(R)","article-title":"Lowe Syndrome","author":"Lewis","year":"1993"},{"key":"10.1016\/j.bbalip.2014.12.001_bb0330","article-title":"OCRL-mutated fibroblasts from patients with Dent-2 disease exhibit INPP5B-independent phenotypic variability relatively to Lowe syndrome cells","author":"Montjean","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0335","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1086\/427887","article-title":"Dent disease with mutations in OCRL1","volume":"76","author":"Hoopes","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0340","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/humu.21391","article-title":"From Lowe syndrome to Dent disease: correlations between mutations of the OCRL1 gene and clinical and biochemical phenotypes","volume":"32","author":"Hichri","year":"2011","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0345","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000213506","article-title":"OCRL1 mutations in Dent 2 patients suggest a mechanism for phenotypic variability","volume":"112","author":"Shrimpton","year":"2009","journal-title":"Nephron Physiol."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0685","doi-asserted-by":"crossref","first-page":"e02975","DOI":"10.7554\/eLife.02975","article-title":"A role of OCRL in clathrin-coated pit dynamics and uncoating revealed by studies of Lowe syndrome cells","volume":"3","author":"N\u00e1ndez","year":"2014","journal-title":"Elife."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0350","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1038\/emboj.2011.354","article-title":"OCRL controls trafficking through early endosomes via PtdIns4,5P(2)-dependent regulation of endosomal actin","volume":"30","author":"Vicinanza","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0355","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.devcel.2007.08.004","article-title":"A role of the Lowe syndrome protein OCRL in early steps of the endocytic pathway","volume":"13","author":"Erdmann","year":"2007","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbalip.2014.12.001_bb0360","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1091\/mbc.E10-08-0730","article-title":"The PH domain proteins IPIP27A and B link OCRL1 to receptor recycling in the endocytic pathway","volume":"22","author":"Noakes","year":"2011","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bbalip.2014.12.001_bb0365","doi-asserted-by":"crossref","first-page":"F335","DOI":"10.1152\/ajprenal.00453.2009","article-title":"OCRL1 function in renal epithelial membrane traffic","volume":"298","author":"Cui","year":"2010","journal-title":"Am. J. Physiol Ren. Physiol."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0370","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.molcel.2006.10.007","article-title":"Mapping the phosphoinositide-binding site on chick cofilin explains how PIP2 regulates the cofilin\u2013actin interaction","volume":"24","author":"Gorbatyuk","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbalip.2014.12.001_bb0375","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1093\/hmg\/dds343","article-title":"The 5-phosphatase OCRL mediates retrograde transport of the mannose 6-phosphate receptor by regulating a Rac1-cofilin signalling module","volume":"21","author":"van Rahden","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0380","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1093\/hmg\/dds163","article-title":"OCRL localizes to the primary cilium: a new role for cilia in Lowe syndrome","volume":"21","author":"Luo","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0385","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4161\/sgtp.19380","article-title":"Crystal structure of the Rab binding domain of OCRL1 in complex with Rab8 and functional implications of the OCRL1\/Rab8 module for Lowe syndrome","volume":"3","author":"Hagemann","year":"2012","journal-title":"Small GTPases"},{"key":"10.1016\/j.bbalip.2014.12.001_bb0390","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1093\/hmg\/ddr615","article-title":"The Lowe syndrome protein OCRL1 is involved in primary cilia assembly","volume":"21","author":"Coon","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0395","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.chom.2012.01.010","article-title":"Yersinia entry into host cells requires Rab5-dependent dephosphorylation of PI(4,5)P(2) and membrane scission","volume":"11","author":"Sarantis","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.bbalip.2014.12.001_bb0400","doi-asserted-by":"crossref","first-page":"13128","DOI":"10.1074\/jbc.M111.315788","article-title":"Phosphatidylinositol 5-phosphatase oculocerebrorenal syndrome of Lowe protein (OCRL) controls actin dynamics during early steps of Listeria monocytogenes infection","volume":"287","author":"Kuhbacher","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0405","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/tra.12195","article-title":"Ciliopathies: the trafficking connection","volume":"15","author":"Madhivanan","year":"2014","journal-title":"Traffic"},{"key":"10.1016\/j.bbalip.2014.12.001_bb0410","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrneph.2009.124","article-title":"Inherited cerebrorenal syndromes","volume":"5","author":"Schurman","year":"2009","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0415","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/cm.21183","article-title":"Oscillatory fluid flow influences primary cilia and microtubule mechanics","volume":"71","author":"Espinha","year":"2014","journal-title":"Cytoskeleton"},{"key":"10.1016\/j.bbalip.2014.12.001_bb0420","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00041552-200309000-00006","article-title":"The renal cell primary cilium functions as a flow sensor","volume":"12","author":"Praetorius","year":"2003","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0425","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.med.52.1.93","article-title":"Molecular genetics and pathogenesis of autosomal dominant polycystic kidney disease","volume":"52","author":"Arnaout","year":"2001","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0430","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/13816810701537424","article-title":"The retinal ciliopathies","volume":"28","author":"Adams","year":"2007","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0435","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S1474-4422(13)70136-4","article-title":"Joubert syndrome: congenital cerebellar ataxia with the molar tooth","volume":"12","author":"Romani","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0440","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/ng.423","article-title":"Mutations in INPP5E, encoding inositol polyphosphate-5-phosphatase E, link phosphatidyl inositol signaling to the ciliopathies","volume":"41","author":"Bielas","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0445","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/sj.ejhg.5201577","article-title":"MORM syndrome (mental retardation, truncal obesity, retinal dystrophy and micropenis), a new autosomal recessive disorder, links to 9q34","volume":"14","author":"Hampshire","year":"2006","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0450","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/ejhg.2012.305","article-title":"Phenotypic spectrum and prevalence of INPP5E mutations in Joubert syndrome and related disorders","volume":"21","author":"Travaglini","year":"2013","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0455","first-page":"29","article-title":"A premature termination mutation in a patient with Lowe syndrome without congenital cataracts: dropping the \u201cO\u201d in OCRL","volume":"225","author":"Pasternack","year":"2013","journal-title":"Klin. Padiatr."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0460","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/jhg.2013.104","article-title":"Novel Fig4 mutations in Yunis\u2013Varon syndrome","volume":"58","author":"Nakajima","year":"2013","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0465","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pneurobio.2012.11.001","article-title":"Fig4 deficiency: a newly emerged lysosomal storage disorder?","volume":"101\u2013102","author":"Martyn","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0470","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1086\/431346","article-title":"Mutations in PIP5K3 are associated with Francois\u2013Neetens mouchetee fleck corneal dystrophy","volume":"77","author":"Li","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0475","first-page":"2776","article-title":"A novel PIKFYVE mutation in fleck corneal dystrophy","volume":"17","author":"Kotoulas","year":"2011","journal-title":"Mol. Vis."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0480","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1091\/mbc.E03-04-0222","article-title":"PIKfyve controls fluid phase endocytosis but not recycling\/degradation of endocytosed receptors or sorting of procathepsin D by regulating multivesicular body morphogenesis","volume":"14","author":"Ikonomov","year":"2003","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bbalip.2014.12.001_bb0485","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1091\/mbc.E06-03-0239","article-title":"Fab1 phosphatidylinositol 3-phosphate 5-kinase controls trafficking but not silencing of endocytosed receptors","volume":"17","author":"Rusten","year":"2006","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bbalip.2014.12.001_bb0490","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1091\/mbc.e05-12-1120","article-title":"The phosphoinositide kinase PIKfyve\/Fab1p regulates terminal lysosome maturation in Caenorhabditis elegans","volume":"17","author":"Nicot","year":"2006","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bbalip.2014.12.001_bb0495","first-page":"373","article-title":"Yunis\u2013Varon syndrome","volume":"42","author":"Bhatia","year":"2005","journal-title":"Indian Pediatr."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0500","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ajhg.2013.05.023","article-title":"SHORT syndrome with partial lipodystrophy due to impaired phosphatidylinositol 3 kinase signaling","volume":"93","author":"Chudasama","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0505","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ajhg.2013.06.005","article-title":"Mutations in PIK3R1 cause SHORT syndrome","volume":"93","author":"Dyment","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0510","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ajhg.2013.05.019","article-title":"PIK3R1 mutations cause syndromic insulin resistance with lipoatrophy","volume":"93","author":"Thauvin-Robinet","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0515","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/cge.12263","article-title":"PIK3R1 mutations in SHORT syndrome","volume":"86","author":"Schroeder","year":"2013","journal-title":"Clin. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0520","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.gde.2014.06.001","article-title":"Recent advances in the study of somatic mosaicism and diseases other than cancer","volume":"26C","author":"Erickson","year":"2014","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0525","article-title":"PIK3CA-related segmental overgrowth","author":"Ghayda Mirzaa","year":"2013","journal-title":"Gene Rev."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0530","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/ajmg.c.31364","article-title":"When overgrowth bumps into cancer: the PTEN-opathies","volume":"163C","author":"Mester","year":"2013","journal-title":"Am. J. Med. Genet. C: Semin. Med. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0535","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nrd4204","article-title":"PI3K and cancer: lessons, challenges and opportunities","volume":"13","author":"Fruman","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0540","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrm3330","article-title":"The functions and regulation of the PTEN tumour suppressor","volume":"13","author":"Song","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0545","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/ejhg.2008.162","article-title":"PTEN hamartoma tumor syndromes","volume":"16","author":"Blumenthal","year":"2008","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0550","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/ng.2332","article-title":"Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA","volume":"44","author":"Lindhurst","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0555","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/ng0597-64","article-title":"Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome","volume":"16","author":"Liaw","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0560","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ng0897-333","article-title":"Germline mutations in PTEN are present in Bannayan\u2013Zonana syndrome","volume":"16","author":"Marsh","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0565","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1590\/abd1806-4841.20132578","article-title":"Cowden Syndrome: report of a case and brief review of literature","volume":"88","author":"Porto","year":"2013","journal-title":"An. Bras. Dermatol."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0570","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/jnci\/djt277","article-title":"Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria","volume":"105","author":"Pilarski","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0575","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1750-1172-9-101","article-title":"Hamartomatous polyposis syndromes: a review","volume":"9","author":"Jelsig","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0580","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/(SICI)1096-8628(19981204)80:4<399::AID-AJMG18>3.0.CO;2-O","article-title":"Germline PTEN mutation in a family with Cowden syndrome and Bannayan\u2013Riley\u2013Ruvalcaba syndrome","volume":"80","author":"Zori","year":"1998","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0585","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJMoa1104017","article-title":"A mosaic activating mutation in AKT1 associated with the Proteus syndrome","volume":"365","author":"Lindhurst","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0590","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ajmg.c.31361","article-title":"Megalencephaly syndromes and activating mutations in the PI3K-AKT pathway: MPPH and MCAP","volume":"163C","author":"Mirzaa","year":"2013","journal-title":"Am. J. Med. Genet. C: Semin. Med. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0595","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.ajhg.2012.05.006","article-title":"Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome","volume":"90","author":"Kurek","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0600","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/ajmg.a.36552","article-title":"Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum","volume":"164","author":"Keppler-Noreuil","year":"2014","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bbalip.2014.12.001_bb0605","first-page":"280","article-title":"PIK3CA mutations in the most common types of cancer","volume":"59","author":"Chomczyk","year":"2013","journal-title":"Postepy Biochem."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0610","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ccr.2005.05.014","article-title":"Mutant PIK3CA promotes cell growth and invasion of human cancer cells","volume":"7","author":"Samuels","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbalip.2014.12.001_bb0615","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fonc.2014.00064","article-title":"Targeting PI3K\/Akt\/mTOR signaling in cancer","volume":"4","author":"Porta","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0620","doi-asserted-by":"crossref","first-page":"e94496","DOI":"10.1371\/journal.pone.0094496","article-title":"Identification of a role for the PI3K\/AKT\/mTOR signaling pathway in innate immune cells","volume":"9","author":"Xie","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2014.12.001_bb0625","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/978-1-4614-3209-8_101","article-title":"Targeting the PI3K\/Akt\/mTOR pathway in ocular neovascularization","volume":"801","author":"Sasore","year":"2014","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0630","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1016\/S1470-2045(14)70052-X","article-title":"Idelalisib: targeting PI3Kdelta in B-cell malignancies","volume":"15","author":"Gilbert","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0635","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/nyas.12036","article-title":"Phosphoinositide 3-kinase and INPP4B in human breast cancer","volume":"1280","author":"Bertucci","year":"2013","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0640","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1158\/0008-5472.CAN-10-2314","article-title":"Decreased expression and androgen regulation of the tumor suppressor gene INPP4B in prostate cancer","volume":"71","author":"Hodgson","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0645","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/jid.2013.511","article-title":"A tumor suppressor function for the lipid phosphatase INPP4B in melanocytic neoplasms","volume":"134","author":"Perez-Lorenzo","year":"2014","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0650","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.canlet.2012.06.009","article-title":"Phosphatidylinositol 4-kinases, phosphatidylinositol 4-phosphate and cancer","volume":"325","author":"Waugh","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0655","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1038\/cddis.2010.84","article-title":"Differential effects of the phosphatidylinositol 4-kinases, PI4KIIalpha and PI4KIIIbeta, on Akt activation and apoptosis","volume":"1","author":"Chu","year":"2010","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0660","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1158\/1541-7786.MCR-13-0604","article-title":"The lipid kinase PI4KIIIbeta is highly expressed in breast tumours and activates Akt in cooperation with Rab11a","volume":"12","author":"Morrow","year":"2014","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0665","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/nature08109","article-title":"GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer","volume":"459","author":"Scott","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bbalip.2014.12.001_bb0670","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ni.2771","article-title":"Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110delta result in T cell senescence and human immunodeficiency","volume":"15","author":"Lucas","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbalip.2014.12.001_bb0675","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1126\/science.1243292","article-title":"Phosphoinositide 3-kinase delta gene mutation predisposes to respiratory infection and airway damage","volume":"342","author":"Angulo","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.bbalip.2014.12.001_bb0680","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1086\/301828","article-title":"Mutations in btk in patients with presumed X-linked agammaglobulinemia","volume":"62","author":"Conley","year":"1998","journal-title":"Am. J. Hum. Genet."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198114002534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198114002534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T22:07:39Z","timestamp":1598566059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198114002534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":137,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S1388198114002534"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2014.12.001","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mendelian disorders of PI metabolizing enzymes","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbalip.2014.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}